{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:03:24Z","timestamp":1792001004959,"version":"4.4.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["101136622"],"award-info":[{"award-number":["101136622"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022850","name":"Little Princess Trust","doi-asserted-by":"publisher","award":["CCLGA 2016 08"],"award-info":[{"award-number":["CCLGA 2016 08"]}],"id":[{"id":"10.13039\/501100022850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000774","name":"Newcastle University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008406","name":"Newcastle University Faculty of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009456","name":"Children's Cancer North","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009456","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.canlet.2026.218583","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:08:20Z","timestamp":1778861300000},"page":"218583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Detection of GD2 negative circulating tumour cells in neuroblastoma by machine learning"],"prefix":"10.1016","volume":"653","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1227-8674","authenticated-orcid":false,"given":"Marina","family":"Danilenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7979-7221","authenticated-orcid":false,"given":"Freya","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8698-6144","authenticated-orcid":false,"given":"Zoe","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8785-8530","authenticated-orcid":false,"given":"Sharanya","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathi","family":"Merugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8957-6609","authenticated-orcid":false,"given":"Lisa M.","family":"Allinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3010-5757","authenticated-orcid":false,"given":"Angharad","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3064-6713","authenticated-orcid":false,"given":"David","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2208-3970","authenticated-orcid":false,"given":"Deborah A.","family":"Tweddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.canlet.2026.218583_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00441-018-2821-2","article-title":"Neuroblastoma: clinical and biological approach to risk stratification and treatment","volume":"372","author":"Tolbert","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.canlet.2026.218583_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.78","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.canlet.2026.218583_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-022-01543-7","article-title":"Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments","volume":"21","author":"Lone","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218583_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13046-020-01601-2","article-title":"Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples","volume":"39","author":"Russano","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218583_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1158\/1078-0432.CCR-19-0656","article-title":"Detection of circulating and disseminated neuroblastoma cells using the ImageStream flow cytometer for use as predictive and pharmacodynamic biomarkers","volume":"26","author":"Merugu","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218583_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00262-021-02963-y","article-title":"Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance","volume":"71","author":"Tibbetts","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2026.218583_bib7","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3389\/fonc.2020.01000","article-title":"Disialoganglioside GD2 expression in solid tumors and role as a target for cancer therapy","volume":"10","author":"Nazha","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218583_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28031","article-title":"The ganglioside G(D2) as a circulating tumor biomarker for neuroblastoma","volume":"67","author":"Balis","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218583_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/pbc.26184","article-title":"Lack of immunocytological GD2 expression on neuroblastoma cells in bone marrow at diagnosis, during treatment, and at recurrence","volume":"64","author":"Schumacher-Kuckelkorn","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2026.218583_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/pbc.20301","article-title":"Lacking immunocytological GD2 expression in neuroblastoma: report of 3 cases","volume":"45","author":"Schumacher-Kuckelkorn","year":"2005","journal-title":"Pediatr. Blood Cancer"},{"issue":"15","key":"10.1016\/j.canlet.2026.218583_bib11","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1158\/1078-0432.CCR-21-1356","article-title":"Immunotherapy of neuroblastoma: facts and hopes","volume":"28","author":"Anderson","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.canlet.2026.218583_bib14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s43018-022-00405-x","article-title":"Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1","volume":"3","author":"Mabe","year":"2022","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218583_bib12","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1038\/s41598-023-32110-9","article-title":"Label-free liquid biopsy through the identification of tumor cells by machine learning-powered tomographic phase imaging flow cytometry","volume":"13","author":"Pirone","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218583_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.939460","article-title":"Pro-metastatic and mesenchymal gene expression signatures characterize circulating tumor cells of neuroblastoma patients with bone marrow metastases and relapse","volume":"12","author":"Loh","year":"2022","journal-title":"Front. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526003460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:29:13Z","timestamp":1783106953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526003460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":14,"alternative-id":["S0304383526003460"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218583","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of GD2 negative circulating tumour cells in neuroblastoma by machine learning","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218583"}}